Form SC 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0001193125-16-611849
Filing Date
2016-06-03
Accepted
2016-06-03 08:00:34
Documents
3
Group Members
NOVARTIS AG

Document Format Files

Seq Description Document Type Size
1 SC 13G d199354dsc13g.htm SC 13G 55994
2 EX-24 d199354dex24.htm EX-24 4624
3 EX-99 d199354dex99.htm EX-99 4456
  Complete submission text file 0001193125-16-611849.txt   66729
Mailing Address C/O NOVARTIS INTERNATIONAL AG WSJ-200.220 CH-4002 BASEL V8 0000000000
Business Address C/O NOVARTIS INTERNATIONAL AG WSJ-200.220 CH-4002 BASEL V8 0000000000 41-61-324-6210
Novartis Bioventures Ltd (Filed by) CIK: 0001297709 (see all company filings)

EIN.: 000000000 | State of Incorp.: D0 | Fiscal Year End: 1231
Type: SC 13G

Mailing Address PADUALAAN 8 POSTVAK 133 UTRECHT P7 3584 CH
Business Address PADUALAAN 8 POSTVAK 133 UTRECHT P7 3584 CH 31 030 253 8800
Merus N.V. (Subject) CIK: 0001651311 (see all company filings)

EIN.: 000000000 | State of Incorp.: P7 | Fiscal Year End: 1231
Type: SC 13G | Act: 34 | File No.: 005-89510 | Film No.: 161694218
SIC: 2834 Pharmaceutical Preparations